NCT02997007

Brief Summary

Healthy ageing and pathological ageing in the context of a neurodegenerative disease are both associated with changes in brain network integrity. Episodic memory is especially affected in Alzheimer's disease, but is also decreased in healthy ageing. Consequently, the memory-relevant brain networks are especially altered. Transcranial direct current stimulation (tDCS) has previously been implemented in different clinical- and non-clinical settings and has shown to beneficially influence network connectivity. The neural correlates of single-session tDCS have been investigated, however, the neural effects of repeated tDCS remain unknown. Furthermore, knowledge about the (long-term) neural mechanisms of repeated tDCS can give valuable insights and possibly pave the ground for exploring tDCS as a treatment option in future studies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2016

Completed
26 days until next milestone

First Posted

Study publicly available on registry

December 19, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

May 2, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

March 26, 2018

Status Verified

March 1, 2018

Enrollment Period

1.6 years

First QC Date

November 23, 2016

Last Update Submit

March 22, 2018

Conditions

Keywords

tDCSMild Cognitive ImpairmentfMRIHealthy ageing

Outcome Measures

Primary Outcomes (2)

  • neural changes after multi-session tDCS

    fMRI-BOLD response

    5-12 days

  • network changes after multi-session tDCS

    functional connectivity between network hubs

    5-12 days

Secondary Outcomes (1)

  • Task performance changes after multi-session tDCS

    5-12 days

Study Arms (4)

MCI-active

EXPERIMENTAL

Patients will receive verum tDCS over the angular gyrus on five consecutive days.

Device: active tDCS

MCI-sham

SHAM COMPARATOR

Patients will receive sham tDCS over the angular gyrus on five consecutive days.

Device: sham tDCS

Healthy Old-active

EXPERIMENTAL

Participants will receive verum tDCS over the angular gyrus on five consecutive days.

Device: active tDCS

Healthy old-sham

SHAM COMPARATOR

Participants will receive sham tDCS over the angular gyrus on five consecutive days.

Device: sham tDCS

Interventions

Participants will receive active tDCS over the angular gyrus on five consecutive days

Healthy Old-activeMCI-active
sham tDCSDEVICE

Participants will receive sham tDCS over the angular gyrus on five consecutive days

Healthy old-shamMCI-sham

Eligibility Criteria

Age60 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients
  • Diagnosis of MCI based on the latest research criteria (clinical assessment at the memory clinic (prof. Frans RJ Verhey): presence of at least a memory impairment, memory complaints expressed by the patient or informant, no problems in daily life functioning, no dementia and presence of biomarkers (Albert et al., 2011)
  • Clinical Dementia Rating score of 0.5 (CDR distinguishes a stage of questionable dementia (CDR 0.5) from people termed healthy (CDR 0) and those with mild dementia (CDR 1)
  • Mini-Mental State Examination (MMSE) 23 and being mentally competent (in general, individuals with a MMSE 18 are considered mentally competent)
  • Age: between 60 and 85 years old
  • % female
  • Right-handedness
  • Average level of education (CBS level 3-4-5-6)
  • Healthy controls
  • Average neuropsychological test results, in accordance with normative data, corrected for age, education and gender
  • No substantial memory complaints (according to the participant)
  • Age: between 60 and 85 years old
  • % female
  • Right-handedness
  • Average level of education (CBS level 3-4-5-6)
  • +1 more criteria

You may not qualify if:

  • Psychoactive medication use
  • Abuse of alcohol and drugs
  • Cognitive impairment due to alcohol/drug abuse or abuse of other substances
  • Past or present psychiatric or neurological disorders (major depression, schizophrenia, bipolar disorder, psychotic disorder (or treatment for it), epilepsy, stroke, Parkinson's disease, multiple sclerosis, brain surgery, brain trauma, electroshock therapy, kidney dialysis, Menière's disease, brain infections)
  • Major vascular disorders (e.g. stroke)
  • Heart diseases or pacemakers
  • Contraindications for scanning (e.g. brain surgery, cardiac pacemaker, metal implants, claustrophobia, body tattoos)
  • Large scars or fresh wounds on the scalp

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University

Maastricht, Limburg, 6221ET, Netherlands

RECRUITING

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Heidi IL Jacobs, PhD

    Maastricht University

    PRINCIPAL INVESTIGATOR
  • Frans RJ Verhey, Professor

    Maastricht University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2016

First Posted

December 19, 2016

Study Start

May 2, 2017

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

March 26, 2018

Record last verified: 2018-03

Locations